← ANALYST RATINGS · TIPRANKS
Oscar Health (OSCR): analyst forecast and price target
Analyst consensus
Hold3 Buy6 Hold1 Sell
Ratings of 10 analysts in the last 3 months12-month forecast
Based on 10 price targets given in the last 3 months, the average target is $35.78, the highest $49.00, the lowest $27.00. The average is +12.2% from the last price of $31.89.
Analyst ratings 11
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Jonathan Yong★★★★★★★★★★#3083 · hits 56% · avg +12.7% | UBS | $26.00 → $36.00+38.5% | Hold | +12.9% | Assigned | 12.10.26on TipRanks 08:15 | +2.0%next day −0.6% | ↗ |
| AI xAi Medical - Healthcare PlansxAI Grok-4 | TipRanks - xAI | $38.00 → $33.00−13.2% | Buy | +3.5% | Reiterated | 25.09.26on TipRanks 10:05 | — | |
| AI DeepSeek Medical - Healthcare PlansDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $37.00 → $33.00−10.8% | Buy | +3.5% | Reiterated | 25.09.26on TipRanks 10:05 | — | |
| AI OpenAI Medical - Healthcare PlansOpenAI 5.2 | TipRanks - OpenAI | $37.00 → $33.00−10.8% | Buy | +3.5% | Reiterated | 25.09.26on TipRanks 10:05 | — | |
| AI Anthropic Medical - Healthcare PlansAnthropic Opus-4.6 | TipRanks - Anthropic | $36.00 → $32.00−11.1% | Buy | +0.3% | Upgrade | 25.09.26on TipRanks 10:05 | — | |
| AI Google Medical - Healthcare PlansGemini 3.1Pro | TipRanks - Google | $39.00 → $34.00−12.8% | Buy | +6.6% | Reiterated | 25.09.26on TipRanks 10:05 | — | |
| AI PerPlexity Medical - Healthcare PlansPerPlexity SonarPro | TipRanks - PerPlexity | $37.00 → $33.00−10.8% | Buy | +3.5% | Reiterated | 25.09.26on TipRanks 10:05 | — | |
| Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% | Piper Sandler | $48.00 | Buy | +50.5% | Reiterated | 23.09.26on TipRanks 08:15 | +0.3%next day −5.4% · 5 days +1.7% | ↗ |
| Parker Snure★★★★★★★★★★#8410 · hits 67% · avg +1.7% | Raymond James | — | Buy | — | Reiterated | 22.09.26on TipRanks 15:35 | −2.0%next day +0.3% · 5 days −1.7% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $31.00 | Hold | −2.8% | Reiterated | 17.09.26on TipRanks 09:26 | −2.2%next day +0.3% · 5 days −10.6% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $27.00 → $33.00+22.2% | Hold | +3.5% | Reiterated | 17.09.26on TipRanks 07:16 | −2.2%next day +0.3% · 5 days −10.6% | ↗ |
| Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% | Goldman Sachs | $30.00 → $34.00+13.3% | Hold | +6.6% | Reiterated | 17.09.26on TipRanks 07:16 | −2.2%next day +0.3% · 5 days −10.6% | ↗ |
| Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% | Bank of America Securities | $30.00 | Sell | −5.9% | Reiterated | 17.09.26on TipRanks 05:08 | −2.2%next day +0.3% · 5 days −10.6% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $39.00 → $49.00+25.6% | Buy | +53.7% | Reiterated | 17.09.26on TipRanks 04:35 | −2.2%next day +0.3% · 5 days −10.6% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $27.00 | Hold | −15.3% | Assigned | 16.09.26on TipRanks Sep 15 13:30 | −3.6%next day +0.1% · 5 days −7.8% | ↗ |
| Kyle Evans★★★★★★★★★★#2012 · hits 51% · avg +16.7% | Stephens | $34.00 | Hold | +6.6% | Reiterated | 07.08.26on TipRanks 07:21 | +4.5%next day −0.8% · 5 days +17.0% | ↗ |
| Justin Lake★★★★★★★★★★#1616 · hits 68% · avg +12.7% | Wolfe Research | — | Hold | — | Initiated | 05.05.26on TipRanks 16:30 | +9.2%next day +5.5% · 5 days +17.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Oscar Health
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $34.67 at a price of $30.84 (+12.4%); now: $35.78 at $31.89 (+12.2%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 3 | 3 |
| Buy | 0 | 1 | 2 | 3 | 4 | 3 |
| Hold | 7 | 9 | 8 | 6 | 8 | 9 |
| Sell | 2 | 2 | 2 | 1 | 2 | 2 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.14 (from $-0.40 to $0.23). Last quarter: $1.10.
Sales
Next quarter’s sales estimate — $4.7B (from $4.4B to $4.9B). Last quarter: $4.9B.
Best top-analyst consensus in the sector · Healthcare
About Oscar Health
- CEO: Mark Thomas Bertolini
- Employees: 2,305
- 75 Varick Street, New York City, NY, 10013, US
- www.hioscar.com
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
Data from the stock’s TipRanks forecast page, read 62 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗